相关实验视频

Updated: Jul 1, 2025

Microfluidic Co-culture of Renal Healthy and Tumor Epithelium to Model Kidney Cancer Progression

Microfluidic Co-culture of Renal Healthy and Tumor Epithelium to Model Kidney Cancer Progression

Published on: January 31, 2025

综合性表观基因组-转录基因组分析揭示了癌症特异性过度表达的基因,这些基因可能会调节清细胞细胞癌中的免疫微环境

Nikhil Gadewal¹, Abhiram Natu², Siddhartha Sen³

¹Bioinformatics & Computational Biology Facility, Advanced Centre for Treatment, Research and Education in Cancer, Tata Memorial Centre, Kharghar, Navi Mumbai, 410210, MH, India; Center for Computational Biology & Translational Research, Amity Institute of Biotechnology, Amity University, Mumbai - Pune Expressway, Bhatan, Post - Somathne, Panvel, Mumbai, 410206, MH, India.

Biochimica et biophysica acta. General subjects

|March 12, 2024

概括

这项研究整合了多个omics数据,以确定清细胞脏细胞癌 (ccRCC) 中的六个关键基因. 这些基因与瘤进展相关,并为ccRCC患者提出新的免疫治疗策略.

科学领域:

在瘤学瘤学.
基因组学就是基因组学.
表观遗传学在表观遗传学中,表观遗传学是指表观遗传学.

背景情况:

清细胞细胞癌 (ccRCC) 是一种流行且具有攻击性的泌尿系统瘤.
整合多学科数据提供了对ccRCC生物学的全面理解,以改善治疗方法.

研究的目的:

使用集成的多omics数据识别与ccRCC进展相关的新基因.
探索已识别的基因在ccRCC患者亚型和治疗策略中的潜力.

主要方法:

综合全基因组DNA甲基组,转录组和ChIP-seq数据 (H3K27ac,H3K4me1,H3K4me3) 针对ccRCC.
选与生存结果相关的高度表达基因,并通过独立数据集验证发现.

主要成果:

在ccRCC中鉴定了6个基因 (RUNX1,MSC,ADA,TREML1,TGFA,VWF) 具有更高的表达,活跃的基因素标记和低甲基化.
这些基因与结节和转移状态相关,途径分析表明激活了与免疫相关的途径.
网络分析表明,这些基因有助于免疫抑制瘤环境.

结论:

多omics分析有效地确定了ccRCC中的关键基因,揭示了它们在瘤进展和免疫抑制中的作用.
这些发现支持患者的亚型,并提出了涉及表观遗传药物的组合疗法,用于增强ccRCC免疫疗法.

关键词:

通过DNA甲基化.表观基因组是一个表观基因组.基因组胺基因的修改免疫系统的免疫系统.ccRCCCC 在线观看

更多相关视频

Author Spotlight: Unveiling Transmembrane Protein Family-Related Markers in Gastric Cancer and Implications for Targeted Therapies

Author Spotlight: Unveiling Transmembrane Protein Family-Related Markers in Gastric Cancer and Implications for Targeted Therapies

Published on: September 15, 2023

Author Spotlight: Impact of Intergenic Interactions on Disease-Identifying Dark Biomarkers

Author Spotlight: Impact of Intergenic Interactions on Disease-Identifying Dark Biomarkers

Published on: March 1, 2024

相关概念视频

The Tumor Microenvironment

The Tumor Microenvironment

Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...

Epigenetic Regulation

Epigenetic Regulation

Epigenetic changes alter the physical structure of the DNA without changing the genetic sequence and often regulate whether genes are turned on or off. This regulation ensures that each cell produces only proteins necessary for its function. For example, proteins that promote bone growth are not produced in muscle cells. Epigenetic mechanisms play an essential role in healthy development. Conversely, precisely regulated epigenetic mechanisms are disrupted in diseases like cancer.
X-chromosome...

mTOR Signaling and Cancer Progression

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...

Cancer-Critical Genes II: Tumor Suppressor Genes

Cancer-Critical Genes II: Tumor Suppressor Genes

Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...

Adaptive Mechanisms in Cancer Cells

Adaptive Mechanisms in Cancer Cells

Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...

lncRNA - Long Non-coding RNAs

lncRNA - Long Non-coding RNAs

In humans, more than 80% of the genome gets transcribed. However, only around 2% of the genome codes for proteins. The remaining part produces non-coding RNAs which includes ribosomal RNAs, transfer RNAs, telomerase RNAs, and regulatory RNAs, among other types. A large number of regulatory non-coding RNAs have been classified into two groups depending upon their length – small non-coding RNAs, such as microRNA, which are less than 200 nucleotides in length, and long non-coding RNA...